Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

MYO vs PWCM: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MYO Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 7–1 Matrix Metrics)

MYO Overall Winner 6-Pillar Tally: MYO 5 – 0 PWCM (1 Tie) Matrix Metrics: MYO 7 – 1 PWCM

As of Nov 20, 2026, Myomo Inc. (MYO) is the stronger overall head-to-head candidate over PWCM (PWCM) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MYO carries a Unified Composite Score of 40.1/100 (SELL) at $0.81 (N/M Forward P/E, -21.8% operating margin), whereas PWCM carries 48.5/100 (HOLD) at $0.35 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While PWCM currently prints a higher short-term Unified Composite Score (48.5/100 HOLD vs. MYO 40.1/100 SELL), MYO captures the overall institutional head-to-head verdict (7–1 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-21.8% vs. N/A operating margin) and revenue trajectory (+22.2% vs. N/A YoY).
  • Technical & Structure Timing Caution: MYO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.7); meanwhile PWCM is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MYO vs PWCM
MYO NYSE American Head-to-Head Winner
Myomo Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.81
-3.45% 1D
Market Cap $33.7M
TTM Revenue $46M
Forward P/E N/M
Beta / 30D Vol 2.22β · 107% Vol
Unified Composite Score
40.1 / 100 SELL
Tech 25.0 Fund 43.0 Flow 58.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.9%), weak momentum, RSI 29
RSI-14: 28.7 · SMA20: $1.16 · SMA50: $1.32
PWCM US Equity
PWCM
Institutional Equity
$0.35
-13.56% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 3.14β · 132% Vol
Unified Composite Score
48.5 / 100 HOLD
Tech 53.0 Fund 51.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -27.5%), weak momentum, RSI 28
RSI-14: 28.1 · SMA20: $0.52 · SMA50: $0.74

6-Pillar Scorecard Institutional Category Breakdown (MYO 5 – 0 PWCM)

Columns: Metric · MYO · PWCM
1. Valuation Multiples MYO
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.9x N/M
2. Growth & Scale MYO
Revenue Growth (YoY) +22.2% N/A
Earnings Growth (YoY) +0.0% N/A
TTM Revenue (USD) $46M N/A
Market Cap $33.7M N/A
3. Profitability & Quality MYO
Gross Margin 70.1% N/A
Operating Margin -21.8% N/A
Net Profit Margin -33.1% N/A
Return on Equity (ROE) -173.5% N/A
4. Balance Sheet & Cash Flow MYO
Cash Generation (TTM) -$9.1M N/A
Cash Flow Margin -20.0% N/A
Net Cash / Leverage $8.9M Net Debt (3.44x D/E) N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning MYO
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 266.0% (81st %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MYO (7) vs PWCM (1)
Institutional Metric MYO PWCM Criterion Row Edge
Market Capitalization
Scale
$33.7M N/A Larger Scale MYO
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+22.2% N/A Higher Growth MYO
Operating Margin (TTM)
Profitability
-21.8% N/A Higher Margin MYO
Net Profit Margin
Profitability
-33.1% N/A Higher Margin MYO
Return on Equity (ROE)
Capital Efficiency
-173.5% N/A Higher ROE MYO
52-Week Range Position
Momentum
16% ($1–$2) 1% ($0–$3) Stronger Trend MYO
Beta / 30D Volatility
Risk Regime
2.22β · 107% Vol 3.14β · 132% Vol Lower Realized Risk MYO
Unified Institutional Score
Composite Signal
40.1 / 100 (SELL) 48.5 / 100 (HOLD) Higher Composite PWCM
Trailing 12M Revenue (USD)
Operating Scale
$46M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
70.1% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.9x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$9.1M ($8.9M Net Debt (3.44x D/E)) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MYO +9.12 pp
MYO: -33.52% · PWCM: -42.64%
3M Horizon MYO +31.9 pp
MYO: -41.65% · PWCM: -73.55%
6M Horizon MYO +62.11 pp
MYO: -22.02% · PWCM: -84.13%
1Y Horizon MYO +62.11 pp
MYO: -22.02% · PWCM: -84.13%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MYO vs PWCM. Trailing 12-month operating profitability (MYO -21.8% vs PWCM N/A) and valuation multiples (MYO N/M vs PWCM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

MYO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$46M
Gross Margin70.1%
Op. Margin-21.8%
ROE / Fwd P/E-173.5% · N/M
PWCM ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MYO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 266.0%
IV Percentile 81st %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact MYO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
PWCM UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PWCM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MYO Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $33.7M market capitalization and -21.8% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
PWCM Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ MYO vs PWCM Key Questions & Quantitative Answers

As of Nov 20, 2026, Myomo Inc. (MYO) is the stronger overall head-to-head candidate over PWCM (PWCM) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MYO carries a Unified Composite Score of 40.1/100 (SELL) at $0.81 (N/M Forward P/E, -21.8% operating margin), whereas PWCM carries 48.5/100 (HOLD) at $0.35 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While PWCM currently prints a higher short-term Unified Composite Score (48.5/100 HOLD vs. MYO 40.1/100 SELL), MYO captures the overall institutional head-to-head verdict (7–1 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-21.8% vs. N/A operating margin) and revenue trajectory (+22.2% vs. N/A YoY). Technical & Structure Timing Caution: MYO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.7); meanwhile PWCM is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

MYO leads the Growth & Scale pillar: MYO posts +22.2% YoY revenue growth and +0.0% YoY earnings growth on $46M TTM revenue (70.1% gross margin, -21.8% operating margin), compared with PWCM at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, MYO generates $46M in USD-normalized revenue versus N/A for PWCM. In operating R&D and SG&A reinvestment, MYO deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for PWCM.

MYO screens cheaper on headline valuation multiples. MYO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.9x EV/Revenue (-20.0% FCF margin), whereas PWCM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MYO (-173.5% ROE) versus PWCM (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, MYO carries 266.0% implied volatility (81st %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.22β · 107% Vol realized risk). By comparison, PWCM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (3.14β · 132% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.